Rare diseases
Investigational molecules
Locations
Study on Dolutegravir and Lamivudine for Maintaining Viral Control in Children with HIV Aged 2 to Under 15 Years
SpainStudy on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis
CzechiaStudy on the Effects of Selgantolimod and NUC Discontinuation in Patients with Chronic Hepatitis B
FranceStudy on the Effects of Ianalumab in Adults with Rheumatoid Arthritis, Systemic Lupus Erythematosus, or Sjögren’s Disease
CzechiaStudy of Injectable Cabotegravir Compared to Oral Emtricitabine/Tenofovir for HIV Prevention in Men Who Have Sex with Men
FranceStudy of tenofovir disoproxil versus placebo for children aged 2-12 years with chronic hepatitis B infection
RomaniaStudy on the Effectiveness and Safety of JNJ-73763989 and Tenofovir Alafenamide in Patients with Hepatitis B and D Co-infection
FranceStudy on the Effects of Doravirine on Liver Health in People Living with HIV with Liver Steatosis or Fibrosis
SpainStudy on Ianalumab for Patients with Systemic Lupus Erythematosus
FranceStudy on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome
AustriaStudy on the Effectiveness of Rilpivirine-Based Treatment for HIV Patients with Metabolic Liver Disease Using Dolutegravir, Rilpivirine, and Emtricitabine/Tenofovir Combination
SpainStudy on the Effects of Peginterferon Alfa-2a, Tobevibart, and Elebsiran in Patients with Chronic Hepatitis B Infection
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
